Bright Peak Therapeutics raises €31.5M Series A round

To capture the expanding opportunities in the field of cytokine therapeutics and beyond, expand its team, and advance its lead program into clinical testing. The company plans to use its platform to create a portfolio of designer cytokines with the potential to be advanced as novel immune-oncology therapeutics.

Source: https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEx11-VP53-Goud-Fe8qk1EZx0cp5YcT4E_CFGq7Wo0Wjl2Rg8RJDaXXrZDuvqmV61Gx35ht_x2JDq99Syd9LJf_a2d4YzkGNL26LXHbciJR9y6AizUyBwmW3DlNT3v-KKKKzj9C6xUPTJDpjXHiaaYdsbVh1l0oGzz3HTHXLKZhNTq0jJWCRA=